Showing results (321-330 of 790) with videos related to
Sort By:
Pageof 79
Plos One|September 13, 2012
Development and validation of a prognostic gene-expression signature for lung adenocarcinomaYun-Yong Park, Eun Sung Park, Sang Bae Kim, et al.Molecular Oncology|April 9, 2013
Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteinsSimen Myhre, Ole-Christian Lingjærde, Bryan T Hennessy, et al.Molecular Cancer Therapeutics|April 14, 2007
Antitumor mechanisms of combined gastrin-releasing peptide receptor and epidermal growth factor receptor targeting in head and neck cancerQing Zhang, Neil E Bhola, Vivian Wai Yan Lui, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Preclinical testing of clinically applicable strategies for overcoming trastuzumab resistance caused by PTEN deficiencyChien-Hsing Lu, Shannon L Wyszomierski, Ling-Ming Tseng, et al.The Journal of Clinical Investigation|November 27, 2008
The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cellsZhen Lu, Robert Z Luo, Yiling Lu, et al.Molecular Carcinogenesis|February 11, 2010
AMPK-mediated phosphorylation of murine p27 at T197 promotes binding of 14-3-3 proteins and increases p27 stabilityJohn D Short, Ruhee Dere, Kevin D Houston, et al.Biorxiv : the Preprint Server for Biology|November 24, 2025
Spatial organization of the tumor-immune microenvironment in ER-positive breast cancer: remodeling during treatment and associations with clinical responseMaria Aanesland Dahle, Jan-Lukas Førde, Eivind Valen Egeland, et al.Cancer Letters|January 15, 2021
Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma modelsChristina A Wicker, Brian G Hunt, Sunil Krishnan, et al.Proceedings of the National Academy of Sciences of the United States of America|July 1, 2020
Fibroblast-tumor cell signaling limits HER2 kinase therapy response via activation of MTOR and antiapoptotic pathwaysIoannis K Zervantonakis, Matthew D Poskus, Alexis L Scott, et al.Science Translational Medicine|August 13, 2025
Sequential treatment with PARPi and WEE1i enhances antitumor immune responses in preclinical models of ovarian cancerXiaofei Jiao, Jiahao Liu, Yijie Wu, et al.Pageof 79